Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed question first answered answering member label
tabling member	label

Search

1682074

registered interest
date	15/01/2024
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Breast Cancer: Screening
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, whether her Department has made a recent assessment of the potential merits of introducing risk assessments using (a) breast density assessment software and (b) other tools during initial breast cancer screening appointments.
tabling member constituency	Streatham
tabling member printed	Bell Ribeiro-Addy
uin	9651
answer	answer is ministerial correction date of answer 22/01/2024 answer text <p>The UK National Screening Committee (UK NSC) is aware of the growing interest in issues related to screening women with dense breast tissue in the National Health Service breast screening programme. In 2019, the UK NSC reviewed the benefit of additional screening with ultrasound after a negative mammography screening, for women with dense breasts. The Committee concluded that there was insufficient evidence to recommend additional screening at that time.</p><p>We are aware of the Breast Screening Risk Adaptive Imaging for Density trial which is investigating the use of supplementary imaging techniques for women within the standard breast screening programme who are found to have radiographically dense breast tissue. The UK NSC will review this evidence when it becomes available.</p> answering member constituency Pendle answering member printed Andrew Stephenson question first answered 22/01/2024 14:41:36 answering member 4044 label Biography information for Andrew Stephenson
tabling member	4764 label Biography information for Bell Ribeiro-Addy

1682076

registered interest
date	15/01/2024
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Breast Cancer: Screening
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, whether she has made an assessment of the potential merits of lowering the breast cancer screening age to 40.
tabling member constituency	Streatham
tabling member printed	Bell Ribeiro-Addy
uin	9653
answer	answer is ministerial correction date of answer 22/01/2024 answer text <p>The UK National Screening Committee (UK NSC) currently recommends that all women aged from 50 years old up to their 71st birthday are invited for breast every three years, which are the parameters used for the national breast screening programme in England. There are circumstances where some women are offered screening more regularly, or outside this age bracket, for example those known to be at very high risk of breast cancer.</p><p>A research trial, AgeX, has been looking at the effectiveness of offering some women one extra screen between the ages of 47 and 49, and one between the ages of 71 and 73. The UK NSC will review the results of this trial as soon as they are available.</p> answering member constituency Pendle answering member printed Andrew Stephenson question first answered 22/01/2024 09:43:33 answering member 4044 label Biography information for Andrew Stephenson
tabling member	4764 label Biography information for Bell Ribeiro-Addy